Pulmatrix, Inc. (NASDAQ:PULM – Get Free Report)’s stock price passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $2.06 and traded as high as $2.06. Pulmatrix shares last traded at $2.00, with a volume of 3,923 shares changing hands.
Analysts Set New Price Targets
Separately, StockNews.com began coverage on shares of Pulmatrix in a research report on Friday. They issued a “hold” rating for the company.
Check Out Our Latest Analysis on PULM
Pulmatrix Price Performance
Pulmatrix (NASDAQ:PULM – Get Free Report) last issued its quarterly earnings results on Tuesday, August 13th. The biotechnology company reported ($0.87) EPS for the quarter. Pulmatrix had a negative return on equity of 46.86% and a negative net margin of 95.18%. The company had revenue of $1.55 million for the quarter.
About Pulmatrix
Pulmatrix, Inc, a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.
Read More
- Five stocks we like better than Pulmatrix
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Trading Stocks: RSI and Why it’s Useful
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- What is the Dow Jones Industrial Average (DJIA)?
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Pulmatrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulmatrix and related companies with MarketBeat.com's FREE daily email newsletter.
